CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Welcome to Capital.com. The products and services listed on this website are not available to US residents.

Trade GlaxoSmithKline PLC - GSKl CFD

13.550
0.15%
0.040
Low: 13.54
High: 13.575
Market Trading Hours* (UTC) Open now
Closes on Thursday at 12:00

Mon - Fri: 08:00 - 12:00 12:03 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.040
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023925 %
Charges from full value of position ($-4.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023925%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002007 %
Charges from full value of position ($0.38)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002007%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5.00%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 13.565
Open 13.55
1-Year Change -12.3%
Day's Range 13.54 - 13.575
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 8, 2025 13.565 0.025 0.18% 13.540 13.605 13.405
Jan 7, 2025 13.435 0.000 0.00% 13.435 13.645 13.180
Jan 6, 2025 13.470 0.095 0.71% 13.375 13.475 13.240
Jan 3, 2025 13.370 -0.180 -1.33% 13.550 13.655 13.360
Jan 2, 2025 13.330 -0.075 -0.56% 13.405 13.645 13.330
Dec 31, 2024 13.390 0.115 0.87% 13.275 13.455 13.275
Dec 30, 2024 13.340 0.015 0.11% 13.325 13.445 13.285
Dec 27, 2024 13.330 -0.030 -0.22% 13.360 13.435 13.135
Dec 24, 2024 13.320 -0.065 -0.49% 13.385 13.450 13.320
Dec 23, 2024 13.295 0.150 1.14% 13.145 13.360 13.145
Dec 20, 2024 13.210 0.155 1.19% 13.055 13.220 12.990
Dec 19, 2024 13.035 -0.165 -1.25% 13.200 13.315 12.990
Dec 18, 2024 13.310 -0.025 -0.19% 13.335 13.370 13.210
Dec 17, 2024 13.190 0.315 2.45% 12.875 13.430 12.875
Dec 16, 2024 13.185 0.035 0.27% 13.150 13.265 13.090
Dec 13, 2024 13.295 0.000 0.00% 13.295 13.340 13.210
Dec 12, 2024 13.355 0.000 0.00% 13.355 13.385 13.190
Dec 11, 2024 13.385 -0.235 -1.73% 13.620 13.660 13.385
Dec 10, 2024 13.590 -0.250 -1.81% 13.840 13.965 13.590
Dec 9, 2024 13.580 0.140 1.04% 13.440 13.845 13.435

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

680K+

Traders

101K+

Active clients monthly

$215B+

Monthly trading volume

$46M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GSK Company profile

GlaxoSmithKline PLC - GSK CFD

GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products. 

The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of  American depositary shares is listed on the New York Stock Exchange.   

GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders. 

In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives. 

Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.

GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.

GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’

The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.

Industry: Pharmaceuticals (NEC)

980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB

People also watch

Gold

2,665.82 Price
+0.090% 1D Chg, %
Long position overnight fee -0.0165%
Short position overnight fee 0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

2.33 Price
-0.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01162

US100

21,121.70 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

ETH/USD

3,319.92 Price
+0.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading